Cabergoline: a review of its use in the inhibition of lactation for women living with HIV.

Karen J TullochPhilippe DodinFannie Tremblay-RacineChelsea ElwoodDeborah MoneyIsabelle Boucoiran

Published in: Journal of the International AIDS Society (2020)

Cabergoline is a safe and effective pharmacologic option for the prevention of physiological lactation and associated physical symptoms in non-breastfeeding women. Future studies should focus on its safety, efficacy and acceptability among WLWH.

Keyphrases

polycystic ovary syndrome
human milk
dairy cows
pregnancy outcomes
physical activity
preterm infants
breast cancer risk
current status
type diabetes
pregnant women
adipose tissue
metabolic syndrome
depressive symptoms
skeletal muscle